[ad_1]
Ukrainian companies and organizations have warned of a possible increase in the level of cyber threats due to theft as a result of a “powerful cyberattack” of tools by the leading US company FireEye.
The latter are convinced that the nature of the theft indicates a high probability of involvement of the Russian special services. This was reported on Facebook by the National Cyber Security Coordination Center (NCCC), which is the working body of the National Security and Defense Council of Ukraine.
It is noted that as a result of the attack on FireEye, digital tools were stolen; With their help, Red Team specialists were able to previously detect vulnerabilities in the security systems of other companies, as well as governments. The hacking data has already been transferred to the US Federal Bureau of Investigation.
“The stolen tools range from simple scripts to automate target data collection to full frameworks like CobaltStrike and Metasploit and do not contain zero-day exploits. They are typically used to proactively check the security status of the network and simulate cyberattacks during cyber operations. “ – says the message.
It is highlighted that the corresponding toolbox It can be used to interfere with networks and information systems.and, under certain conditions, even as a cybernetic weapon.
“According to FireEye, the nature of the hack indicates a high probability of involvement of Russian special services in this cyber attack. Given the increasing number of incidents, we record that this indicates a growing cyber threat for Ukrainian information systems, especially before the New Years holidays and the likely introduction ofby quarantine measures “, – declared in the NCCC.
They ask to immediately report possible problems in case of detection of cyber incidents or indications of a cyber attack.
As reported by OBOZREVATEL, on December 9 a cyber attack was carried out on the servers of the European Medicines Agency. As a result, the hackers gained access to technical information about the vaccine developed by BioNTech and Pfizer against COVID-19.
